Articles for tag: Alkem, CDSCOs, Claiming, Clavam, Denies, Failures, Laboratories, PanD, Quality, samples, spurious, Test

Market News

Alkem Laboratories denies quality test failures, claiming CDSCO’s samples of Pan-D and Clavam 625 are spurious and not theirs.

Alkem Laboratories denies quality test failures, claiming CDSCO’s samples of Pan-D and Clavam 625 are spurious and not theirs.

Alkem Laboratories, based in Mumbai, has denied reports that its products Pan-D and Clavam 625 failed quality tests by the Central Drugs Standard Control Organisation (CDSCO). This follows a CDSCO alert stating that these drugs were found to be Not of Standard Quality. Alkem claims that the tested samples were not their products but instead ...

DeFi Explained: Simple Guide Green Crypto and Sustainability China’s Stock Market Rally and Outlook The Future of NFTs The Rise of AI in Crypto